CLSI EP26-Ed2-IG

CLSI EP26-Ed2-IG

Click here to purchase

This implementation guide describes the minimum procedures necessary for a medical laboratory to verify that new reagent lots, when received and implemented by the laboratory, will produce results consistent with previous reagent lots. Reagent lot performance is validated by the developer before release and distribution; however, the laboratory needs to verify each new reagent lot it receives. Changes in performance with a new reagent lot could be due to:
• Changes in reagent component materials
• Instability of a component in a reagent
• Reagents that were compromised in transportation or storage
• Incorrect calibration of the new reagent lot

Verifying that these potential changes have not occurred is important to ensure the quality of laboratory results. For additional information on the acceptability of a reagent lot change, see CLSI document EP26.1

Product Details

Published:
11/01/2022
ISBN(s):
9781684401390
Number of Pages:
14
File Size:
1 file , 920 KB
Note:
This product is unavailable in Russia, Belarus

You may also like

CLSI VET01S

CLSI VET01S

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 6th Edition, VET01SEd6Estandard by Clinical and...

CLSI EP33

CLSI EP33

Use of Delta Checks in the Medical Laboratory, 2nd Edition, EP33Ed2Estandard by Clinical and Laboratory Standards Institute, 06/01/2023

CLSI EP25-Ed2

CLSI EP25-Ed2

Evaluation of Stability of In Vitro Medical Laboratory Test Reagents, 2nd Edition, EP25Ed2Estandard by Clinical and Laboratory Standards Institute, 04/26/2023

CLSI PRE04

CLSI PRE04

Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations, 1st Edition, PRE04Ed1Estandard by Clinical and Laboratory Standards...

Back to Top